Table 1: Anti CCP 2 antibody and RF in RA and healthy control group.

RA UNTREATED GROUP NO 35
VALUE ( M ± SD )		 RAsero-
NO 18
VALUE ( M ± SD )		 RAsero+
NO 17
VALUE ( M ± SD )		 HEALTHY CONTROL
GROUP NO 35
VALUE ( M ± SD )
Positive / Negative Positive / Negative Positive / Negative Positive / Negative
ACPA
+ > 1,26 U/ml		 23/12
1,71 (± 0,69 )
( 0,92-3,0 )		 11/7
1,56 ( ± 0,59 )
( 0,93-2,6 )		 12/5
1,87 ( ± 0,77 )
( 0,92-3,0 )		 1/34
0,95 ( ± 0,10 )
( 0,90-1,38 )
DAS 28
+ > 3,2		 28/7
4,79 (± 1,56 )
( 1,85-7,03 )		 13/5
4,56 ( ± 1,76 )
( 1,85-7,03 )		 15/2
5,04 ( ± 1,33 )
( 2,47-6,83 )		 0/35
0,00 ( ± 0,00 )
( 0,00-0,00 )
RF
+ 30 > IU/ml		 17/18
346,15 ( ± 625,22 )
( 0,00-1920 )		 0/18
0,00 ( ± 0,00 )
( 0,00-0,00 )		 17/0
712,67 ( ± 743,72 )
( 30-1920 )		 2/33
13,71 ( ± 38,73 )
( 0,00-120 )
CRP
+ 12 > mg/L		 14/21
46,86 ( ± 79,19 )
( 0,00-384 )		 3/15
8,66 ( ± 24,62 )
( 0,00-96 )		 13/4
87,31 ( ± 96,44 )
( 0,00-384 )		 4/31
5,48 ( ± 12,80 )
( 0,00-48 )
SEDIMENTATION
+ > 16		 27/8
48,62 ( ± 39,81 )
( 2,0-120 )		 13/5
43,94 ( ± 39,82 )
( 2,0-120 )		 14/3
53,58 ( ± 40,39 )
( 5,0-120 )		 4/31
9,42 ( ± 8,21 ) ( 2,0-44 )